Next-generation sequencing (NGS) has transformed how clinicians approach biomarker testing in solid tumors, according to ...
Biomarker testing helps identify effective targeted therapies and avoid those that are less likely to work in certain ...
Recognized in the Healthcare category of the 2025 Top Innovations contest, Haystack MRD® enables minimal residual disease ...
This insightful review explores key areas of cancer genetic research, focusing on genes that may benefit from ...
Pansarcoma Analysis of Cyclin-Dependent Kinase and Cyclin Outlier Gene Expression Highlights CDK7 as a Potential Therapeutic Target in Chordoma Human epidermal growth factor 2 (HER2/ERBB2) has ...
In a city, coworking hubs bring people and ideas together. Inside cancer cells, similar hubs form—but instead of fueling ...
The U.S. Food and Drug Administration (FDA) has approved Revuforj (revumenib), which is a menin inhibitor, for the treatment ...